VR

Venkata Ramana Kumar Doddi

Active Director Director DIN 11001996
DIN 11001996 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Ramana Kumar Doddi

Data last updated:

Venkata Ramana Kumar Doddi is a Director at Medway Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 11001996
Primary Designation Director
Industry Pharma
First Appointment 02 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medway Pharma Private Limited U46497AP2025PTC118625
Director02 Apr 20252025Active

Board colleagues of Venkata Ramana Kumar Doddi

Directorship timeline

Open interactive timeline →
Medway Pharma Private Limited
Premium access

Shareholding and investment profile for Venkata Ramana Kumar Doddi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Ramana Kumar Doddi

Venkata Ramana Kumar Doddi currently holds 1 directorship: Medway Pharma Private Limited (Director, since 02 Apr 2025).

Venkata Ramana Kumar Doddi was first appointed on 02 Apr 2025 as Director at Medway Pharma Private Limited.

The current boards of Venkata Ramana Kumar Doddi's companies include Gurudev Pukkalla (Medway Pharma Private Limited), Srinivasa Rao Kandi (Medway Pharma Private Limited), Venkata Suresh Boppana (Medway Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available